Member Info for slipperyslope

than ever on here these days which means that a lot of people showing a lot of interest. Usually for one reason only to make money in this game. I thought that the addition of Christopher McLaughlin to the Board was interesting when you look at his CV. It does appear that Avanti will now be looking to push the company along the lines of Isat for better future revenues which again is what it is all about. Still think we might see an Avanti/Isat tie up once Hylas 4 is up and running with Avanti having a stronger bargaining position.

For references and news see also RNS 29 03 17 no 8102A re partnership with Millicom, plus RNS 46890 of 21.08.17 re Hylas 4 Launch where it is said Hylas 4 revenues would be expected to flow from July 2018. Should get some more news on how revenues are going at end of this Qtr from current fleet which should be on the increase in this new financial year as per RNS No. 0349K dated 04.07.17. Good weekend all.

WO, You beat me to that one. I was just going to post the same thing. Well something similar anyway. Amazing how some folks just do not do their research on these things.

Interesting how we are both referred to as SS. South for you and a Slope for me. It is true that I never listen to others or take notice of anything posted on the boards. Learned that lesson years ago. My best investment is NMC which has done well along with CVSG and they are my only UK stocks at the moment. Mainly invest in the US stocks and did well with FB 5 years ago when it dropped to US$18 and everyone was saying sell. Well I loaded up and 10 bagged with that one and still holding. Mainly like the US Mega-Cap FANG stocks over last 5 years and recently added Snap to these on its drop to US$12. Everyone is saying sell that one but it is said that Google recently bid over US$30 Billion for Snap before it went public so I can see it doing well over the next 5 years. Now I suppose I am invested mainly in FANGS. LOL. Good luck with your investing SS. I would not watch this one anymore as you will be kicking yourself 'North' for selling at this price.

Can see this ticking along at current levels until we see next round of revenue updates and we get closer to Hylas 4 launch. Volatility is now being reported and in such a bull market can expect canny investors to be watching this one to see how the company has fared over the last quarter and no doubt using these opportunities to buy at this discount price. Surprised to note that SouthStreet was a seller now when I didn't know he was a buyer at any time. Certainly worth keeping a watch on this one over coming months.

That makes 20 posts today which helps sum up my point as well. Opps 21 now I have posted this. Keep up the both negative and plus posts that's what this forum is all about. I have been investing in Avanti for the last 5 years highest price paid was £4. But I have always traded these and come out on top even with a declining sp. I tend to follow the Rothschild method of investing which has always stood be in good stead over the years.

What I have noticed that has increased on here of late is the number of members posts. Used to only get 2 or 3 a day. That has increased by about 500% which is about the average I expect the sp to increase over the next year. This is also usually a sign that members are becoming interested in this beaten down stock no doubt with one thing on their mind!!!! Have a good weekend folks. Weather don't look it is going to be great here but better than the poor folks in the Caribbean and Florida. Wishing those folks all the best and hope they all stay safe.

Nice to see this moving up above the 2800 marker. The future looks even better for NMC based on latest reports etc.

A little gem for me this week. Managed to buy in in various tranches between 250 and 270 to sell today at 300. Will keep a watch on this one to see how it goes. Looks a bit of a wet Friday today though. GLA

Worth having a read of the 'full' Edison report on AVN at Edisoninvestmentresearch.com rather than some of the rubbish you get on here these days. Their fair value is now 93p reduced from 109p based on long term assumptions. The one analyst FT view as at 1st September 2017 is that over the next year the sp will rise to 25p an approximate 200% increase based on anticipated revenue. Certainly contracts and revenue stream had started to pick up as mentioned in the last annual report from Avanti. All very much depends on how the revenue stream for Avanti goes but it is gradually increasing albeit at a much slower rate than first anticipated when company set up with bullish sp targets of over £20. Probably why Co-Founder and CEO decided to leave things to someone else. They do have a lot of debt but so do most companies in this business as it goes with the territory. Launching Satellites does not come cheap. The cloud on the horizon is Oneweb/Airbus but that is going to take a long time to put in to place and they have the clout to possibly buy out Avanti which could still come from a number of sources. Those getting in now could start to see some reasonable financial rewards but this is not for the faint hearted that is for sure.

"The one positive from this news is that Indivior's patents were upheld, and Dr Reddy's was found to not be infringing on said patents. This could potentially help offset any future generic challenges, as must also show to not be infringing. This could limit the number of competitors and hence the market share loss of Subuxone Film." RBC's model suggested a range of 350p-422p was possible for Indivior's shares, with the upper end suggesting its RBP6000 subcutaneous long-acting monthly depot injection of buprenorphine could receive regulatory approval by the end of November even if Dr Reddy's launches and Indivior loses 20% market share per year from 2018. The note, written before trading in London began and the shares lost almost 40% to 251.2p, RBC said a big fall in the shares could present an opportunity for investors. The 350p price would assume 20% annual revenue loss of Subuxone film starting in the second half of 2018, which assumes Dr Reddy's launches post FDA approval and at risk and would equate to a price/earnings ratio of 17.7, 22.6 and 28.2 based on the 2018, 2019 and 2020 forecasts and noting that Indivior would be sat on $1bn of cash by end-2019.

That should have said 'recognition' but maybe reconnection is what is needed now.

For a company that received the UK's highest accolade 'The Queen's Award for Enterprise' for International Trade and business success, in reconnection of outstanding achievement in delivering growth in exports, etc.etc.etc. Plus what with contracts and help from the likes of ESA and foreign governments, Avanti has to do well or else. We all need to be backing companies like this and giving our full support what with Brexit an all, these are our future. Hopefully Theresa Maybe is selling some slots to the Japanese who may now need to have some extra special super spy satellites in place. Anyone got her number to send her a text message.

With the contracts that were coming through at the end of the last trading year should see revenues start to pick up. Along with the launch in March of Hylas 4 should see the sp move up. I see that analysts give the sp prediction anywhere between 25p from the FT up to 250p. Certainly the sp is at a bargain basement price with high growth potential from here and possible multi bagger if they can bring in the revenues.

Certainly looking like another good day for NMC and positive move is=n sp. Been here now for the last 3 years so no complaints from me.

Welcome aboard. This tends to be my main holding these days along with some of the US mega cap stocks. Anything to do with the UK seems to end up going the same way as PFG these days. Don't get too many posters on here which is probably a good thing. Best keep this our little secret so we don't get any riff raff turning up and spoiling things.

out today with everything performing well and in line with expectations. Some aspects of the business exceeding expectations and we also have another RNS with details a new O&M contract for the management of Emirates Healthcare assets. The future all looking very bright and positive for this company. Sp has however bounced back over the last couple of weeks to all time highs so not sure the report will have a marked impact on the current sp but still hold for me. · Emirates Hospitals and Clinics: General medical services across six Emirates in the UAE · CosmeSurge: Provider of cosmetic medical services in the UAE with 1 clinic in the UK · Emirates Rehab and Homecare Services: Rehabilitation segment that provides home nursing, rehabilitation, therapeutic care and home-based care. Present in the UAE, Slovakia and Oman

The departure of co-founder Williams was a bit of a surprise. Indicates that there has been some heated boardroom discussions over the last year No doubt the major players who hold over 60% of the stock want to know what is going on and want to see some return on their large investment. The putting up the 'For Sale' sign was obviously the wrong move and has hit sales. Interesting to see the change of direction for Avanti which I suspect Williams probably objected and reason for him being ousted. However, with the threat around the corner of OneWeb from Airbus it is probably the only option. Interesting also that Avanti now looking to follow a similar investment area to that of Isat. Could be that Avanti and Isat will eventually tie-up and make a bigger market force which would now make sense.

Duly noted. It has had a good run as you say and sp is still looking on a bit of a downward trend from its all time highs. Be interesting to see how the year end results and trading update to 30th June look like. These usually come out towards the end of this month. We did have the usual drop to the July trading statement last year which gave us some positive news and outlook which pushed the sp all the way up from 650 to 1400. Worth keeping an eye out for that July trading statement to see how things are going and future prospects.

I see this was one of the recommended stocks recently in the Mail on Sunday Midas column. Does now look to be a good time to get back in as buy signals now growing strong for after this latest dip in sp.